Legend Biotech Co. (NASDAQ:LEGN – Get Rating) has received an average rating of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among analysts that have […]
Zacks Investment Research upgraded shares of Legend Biotech (NASDAQ:LEGN – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday morning, Zacks.com reports. According to Zacks, “Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and […]